Psilocybin Shows Promise in Preventing Chemotherapy Nerve Damage

Among the many burdens carried by those who endure chemotherapy, the slow destruction of peripheral nerves has long been accepted as an unavoidable cost of survival — a cruelty layered upon crisis. Now, early laboratory research suggests that psilocybin, the psychoactive compound long associated with altered consciousness, may hold an unexpected capacity to shield those nerves from chemotherapy's collateral damage. The findings remain preclinical, rooted in cellular and animal models rather than human experience, but they invite a serious reconsideration of what medicine might borrow from the